BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol 2021;12:735965. [PMID: 34987385 DOI: 10.3389/fphar.2021.735965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Yan Y, Cai Y, Liang Q, Liu Y, Peng B, Xu Z, Liu W. Current insights into the functional roles of ferroptosis in musculoskeletal diseases and therapeutic implications. Front Cell Dev Biol 2023;11. [DOI: 10.3389/fcell.2023.1112751] [Reference Citation Analysis]
2 Meng X, Lu Z, Zhang L, Wang Z. A pH/ATP-responsive nanomedicine via disrupting multipath homeostasis of ferroptosis for enhanced cancer therapy. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.141313] [Reference Citation Analysis]
3 Kavvadas E. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022;167:110944. [DOI: 10.1016/j.mehy.2022.110944] [Reference Citation Analysis]
4 Cheng K, Guo Q, Shen Z, Yang W, Zhou Y, Sun Z, Yao X, Wu H. Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field. Front Oncol 2022;12:948389. [DOI: 10.3389/fonc.2022.948389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yu H, Han Z, Chen C, Zhang L. Nanomaterials as Novel Biomarkers for Cancer Nanotheranostics: State of the Art. Biotechnology - Biosensors, Biomaterials and Tissue Engineering - Annual Volume 2022 [Working Title] 2022. [DOI: 10.5772/intechopen.105700] [Reference Citation Analysis]
6 Zhang L, Cai H. Cancer Immunotherapy and Cytotoxicity: Current Advances and Challenges. Cytotoxicity [Working Title] 2022. [DOI: 10.5772/intechopen.105184] [Reference Citation Analysis]